Status:
COMPLETED
The Effect of a Self-Management Program on Individuals With Scleroderma
Lead Sponsor:
Emirhan Karakuş
Conditions:
Scleroderma
Systemic Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Introduction: Individuals with systemic sclerosis (SSc) have problems with perceived occupational performance and satisfaction in daily life activities due to many symptoms caused by the disease. Pur...
Detailed Description
In this study, 36 individuals, diagnosed with scleroderma by a rheumatologist at Gazi University, were included. In the study approved by the Gazi University Clinical Research Ethics Committee (21.09....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinical diagnosis of Scleroderma's Disease, being in remission period for 6 months, being between the ages of 18-65, knowing how to use technological devices.
- Exclusion criteria:
- Neurological disease, continuing a different study or rehabilitation programme, having COVID-19 infection, exacerbation the disease in the last 6 months.
Exclusion
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT06095921
Start Date
July 15 2020
End Date
January 15 2021
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Çankaya, Ankara, Turkey (Türkiye), 06060